Elanco Rebates

You're in the right place to redeem a rebate.

Find an offer to redeem by searching with your offer code or browsing the list of available offers to redeem below.

How It Works

Redeem a New Rebate

If you don’t know your rebate offer code, view the list of available rebates below.

Browse All Rebates

Filter by:
Rebate OfferOffer CodeOffer DetailsRebate ValueValid Purchase DatesSubmission Deadline
Offer CodeCRD2023Offer Details

6 doses
12 doses

Rebate Value

$15
$35

Valid Purchase Dates1/1/23 - 12/31/23 Valid Purchase Dates3/1/2024Claim Rebate
    Offer CodeCAT2023Offer Details

    6 doses

    Rebate Value

    $15

    Valid Purchase Dates1/1/23 - 12/31/23Valid Purchase Dates3/1/2024Claim Rebate
      Offer CodeINT2023Offer Details

      6 doses
      12 doses

      Rebate Value

      $6
      $15

      Valid Purchase Dates1/1/23 - 12/31/23Valid Purchase Dates3/1/2024Claim Rebate

      Offer also valid for Interceptor® (milbemycin oxime) purchases.

        Offer CodeINCR23Offer Details

        6 doses of each product
        12 doses of each product

        Rebate Value

        $25
        $75

        Valid Purchase Dates1/1/23 - 12/31/23Valid Purchase Dates3/1/2024Claim Rebate

        Offer also valid for Interceptor® (milbemycin oxime) purchases.

          Offer CodeSER2023Offer Details

          1 collar

          Rebate Value

          $10

          Valid Purchase Dates1/1/23 - 12/31/23Valid Purchase Dates3/1/2024Claim Rebate
            Offer CodeINSER23Offer Details

            1 collar and 6 doses

            Rebate Value

            $20

            Valid Purchase Dates1/1/23- 12/31/23Valid Purchase Dates3/1/2024Claim Rebate

            Offer also valid for Interceptor® (milbemycin oxime) purchases.


              Bexacat™ (bexagliflozin tablets)

              Important Safety Information:
              Before using this product, it is important to read the entire product insert, including the boxed warning. See package insert for full prescribing information.

              Cats treated with Bexacat may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of Bexacat. Do not use Bexacat in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of Bexacat in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of Bexacat, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death. Sudden onset of hyporexia/anorexia, lethargy, dehydration, diarrhea that is unresponsive to conventional therapy, or weight loss in cats receiving Bexacat should prompt immediate discontinuation of Bexacat and assessment for diabetic ketoacidosis, regardless of blood glucose level. Bexacat should not be initiated in cats with pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis. Due to risk of severe adverse reactions, do not use Bexacat in cats with evidence of hepatic disease or reduced renal function. Consult a physician in case of accidental ingestion by humans.

              PM-US-22-2230 | PM-US-22-2236

              Date of review January 2023

              © 2023 Elanco or its affiliates